X-Message-Number: 7625 Date: Mon, 3 Feb 1997 02:56:23 -0500 (EST) From: Charles Platt <> Subject: Report from the Alcor Technology Festival Report from the Alcor Technology Festival by Charles Platt This report is being typed late on Sunday, February 2. I will not have time to do an immaculate job, here, but want to circulate the news as fully and promptly as possible. The report is in four parts: 1. The Rat Heart Demo 2. Conclusions 3. Other News About Olga Visser 4. The Mystery Ingredient--Revealed 1. The Rat Heart Demo Even the most antagonistic observer had to feel some sympathy for Olga Visser when she failed for the fourth time to resuscitate a frozen rat heart on Sunday, February 2nd, at the Alcor Cryonics Technology Festival. Ms. Visser, who has more stamina and determination than her lean, petite physique suggests, started her first experiment around 9:30 AM at the Alcor facility in Scottsdale, Arizona. By 11 AM an audience of 30 visitors had gathered in the adjacent room, where a large TV showed generally excellent close-up pictures from Fred Chamberlain's camcorder, which he had mounted on a small tripod about 18 inches away from procedures on the lab bench. Attendees were allowed to make brief personal visits to the lab area, and photographs were permitted without any restrictions. I took many pictures, some of which will appear in the next CryoCare Report. Ms. Visser worked with intent, bird like motions, sometimes standing, sometimes sitting in front of a metal rack supporting several vertical tubes drip-fed by small bottles of colorless fluid. Hugh Hixon sat beside her, watching temperature graphs on a computer screen, while Fred Chamberlain, in a jacket and tie, sat at an adjacent desk monitoring his camcorder. During a brief appearance before an audience the previous day, Ms. Visser was asked why she often immersed rat hearts in liquid nitrogen for only 60 to 90 seconds. Some conference attendees speculated openly that by using cotton balls to wrap the hearts, she was protecting them from being cooled fully to -196 Celsius. This suspicion intensified when we learned that a temperature probe is not inserted in the heart itself, or attached to its exterior. Also, since the cotton wrapping the heart is wet, the water will liberate heat during its change of state to ice, providing additional protection. Ms. Visser's response to these criticisms was immediate and unflinching. She had no doubt, she said, that the hearts were being frozen to -196. Therefore, it would make no difference if they were maintained for 60 seconds or 60 days; and she vowed to freeze her hearts today for a full 20 minutes. Initially she perfused a heart for about half an hour with her secret cryoprotectant, at a temperature between 1 and 2 degrees Celsius. Perfusion is a three-stage process, which I believe ramps up from weak concentrations to a final value of 20 percent. A gas mixture of 95 percent oxygen, 5 percent carbon dioxide is bubbled into her cryoprotectant. She uses a simple gravity-drip-feed connected to a cannula that is placed in the aorta of the heart. As I understand it, she perfuses a fixed volume of cryoprotectant, for whatever length of time it takes. In her demonstration today she then disconnected the heart from the cannula, wrapped it in cotton balls, and placed this mass in a thin-walled plastic cup (very similar to the little cups that dairy creamer is served in, in fast-food restaurants). A rubber band was stretched around the mouth of the cup, and the cup was then placed in some Dacron wool inside a Coke can from which the top had been removed. This, according to Ms. Visser, was her way of simulating a cryonics patient being placed in a dewar. The Coke can was then dunked in a real (small) dewar of liquid nitrogen. Observers verified that the can was fully immersed beneath the surface. Twenty minutes later, it was removed. The cotton mass--now frozen--was dunked in a concentrated solution of the Visser cryoprotectant, and was allowed to soak for about ten minutes before she started prying the cotton away with tweezers. About another ten minutes later the heart was revealed, and was a healthy red- brown color. She reattached it to the cannula and recommenced flowing cryoprotectant solution through it, gradually warming it to room temperature. This, of course, was the moment everyone had been waiting for. While conference attendees watched impatiently, Ms. Visser tapped the heart, shook it, prodded it, massaged it, and forced additional fluid through it under high pressure from a large syringe. Finally she pierced it with three EEG probes whose signals were displayed on a CRT screen in a unit that also emitted audible beeps. The beeps, however, were erratic and seemed to be generated each time the assembly was moved or shaken. When Ms. Visser allowed the heart to dangle undisturbed from its cannula, the beeps settled into a steady rhythm--which coincided precisely with drips of cryoprotectant falling from the bottom of the heart, and seemed to be caused entirely by the associated fluctuation in conductivity. Ms. Visser suggested that the heart was in fact pumping the cryoprotectant through it, but no contractions were visible. Undaunted, Ms. Visser walked into the other room and told the audience that the beeps indicated weak ventricular contractions. This was politely disputed by two attendees, one of them with formal training as an EEG technician. It was also noted that the heart had lost its healthy color and turned gray after being warmed to room temperature. The blanching indicated typical post-freezing injury, and the resistance to free flow of fluid through the heart suggested that the capillary bed had been damaged by freezing. This was confirmed a little later when the heart was disconnected from its cannula and cut open. Even Ms. Visser's supporters were forced to admit that this heart had not, in fact, resumed beating. Two of them claimed that they had witnessed a successful experiment on the previous Friday, when Ms. Visser had arrived to practice her techniques at the Alcor facility. On that occasion, according to two witnesses, a heart had pulsed visibly--but this was a heart that had been immersed in liquid nitrogen for only one minute. Moreover, even that trial had been preceded by unsuccessful attempts. Today (Sunday) Ms. Visser told us that she might not have time to try again with a second heart. She said that a mistake had been made; her flight back to South Africa was supposed to be on Monday, but when she looked at her ticket this morning she saw that it was valid for this afternoon. She also said that it was important to buy gifts for her children, and she planned to go shopping before heading out to the airport. This caused some consternation among Alcor personnel, who huddled briefly with Ms. Visser, called the airline, and arranged for her ticket to be changed so that she would return home tomorrow (Monday) as originally promised. Ms. Visser now had no reason to leave the lab, so she set to work on another rat. By this time the audience had thinned out considerably, and I believe some of the people left under the impression that the first trial had been a success. Clearly this was not the case, since the heart had showed such clear evidence of severe freezing damage, and no contractions had been visible. The full cycle of dissection/perfusion/immersion/reperfusion takes about two hours, and entails long periods during which there is no action at all. The Alcor facility turned into a low-key non-alcoholic cocktail party as people wandered from room to room, socializing on a cordial basis. There was no sign of any animosity, and indeed I believe everyone wanted the Visser experiment to be a success. Our future, as cryonicists, would obviously be enhanced by any breakthrough in cryoprotectants. Alas, Ms. Visser's second heart of the day was even less successful than the first. It failed almost completely to reperfuse, and one observer judged that it was grossly edematous. Ms. Visser is a determined woman, however, and promptly started work on her heart. At this point I left, because the first two experiments had been so unsuccessful, I found it hard to believe that the third would do any better. Also the event was beginning to remind me of experiments to detect psychic phenomena, which always seem to fail while skeptics are around. I was frankly embarrassed on behalf of Ms. Visser, who I think is a sincere woman who believes in her work. I returned to the lab around 5 PM and found it virtually empty. I was told that the third heart had been another failure, and everyone had gone out to dinner. This turned out to be a long break; Ms. Visser didn't show up till around 7:30, holding a large sandwich. After eating it, she killed another rat and set to work on her fourth heart. By this time the audience had shrunk to only seven hard-core research enthusiasts: Mike Darwin, Sandra Russell, and Joan O'Farrell (all from BioPreservation/21st Century Medicine), myself, Erico Narita, and two others whose names I won't include because I don't know if they would wish to be mentioned. Hugh Hixon, Fred Chamberlain, Linda Chamberlain, and Steve Bridge were also present. The fourth heart was a problem even before it was frozen. For reasons that no one could understand it perfused extremely slowly, as if it contained some kind of interior obstruction. This time Ms. Visser wrapped it in a thicker layer of cotton (by my visual estimation) and immersed it in liquid nitrogen for only four-and-a-half minutes. To no avail: the heart showed significant cracks when it was removed from its coccoon, and was clearly damaged beyond repair. Ms. Visser shook hands all around, we thanked her for her efforts, and the visitors left the lab. Conclusions Absence of evidence is not, as the saying goes, evidence of absence. The failure of the four trials that we witnessed does not prove that Ms. Visser's cryoprotectant is useless. There are still reports that on other occasions, she has been successful. Tanya Jones, Alcor's Director of Suspension Services for the past four or five years, told me that she saw clearly visible contractions of a heart that had been placed in liquid nitrogen for several minutes. Still, I have to say I was troubled by the obvious lack of experimental rigor. Ms. Visser changes her parameters and procedures in an impulsive style, like a chef deciding to add a little more salt or a little less sugar each time she cooks a particular dish. I was told that the final concentration of her solution was 25 percent during some previous trials; tonight, for reasons unspecified, it was 20 percent. The procedure for wrapping the heart seemed to vary from one time to the next, and the Coke can was pre-filled with liquid nitrogen during the second trial that I witnessed, while it was not pre-filled during the first trial (so far as I was able to see). I am also troubled by Ms. Visser's initial claim that the first heart in today's series was a success. She did not formally retract this claim, but ultimately did admit that her experiments today were a failure. Of course I realize that she was operating under considerable pressure, in front of an audience containing several critics, and she must have felt a great need to vindicate her procedure. This cannot excuse, however, a false claim; and a false claim was made. It remains unclear whether her procedure for wrapping rat hearts does in fact provide significant protection from liquid-nitrogen temperatures. When challenged on this subject today, she cut off a piece of rat liver, approximately the same size as a heart, wrapped it in cotton, dunked it for 90 seconds, then removed it and applied a temperature probe that showed it was, in fact, below -190 Celsius. On the other hand, I noticed that in her fourth heart today she added considerably more protective cotton. I also noticed that Alcor personnel did not always check that her hearts were completely immersed in the dewar of liquid nitrogen. Even if they had been more rigorous, immersion is almost impossible to judge during a short period, because vapor in the dewar takes a couple of minutes to clear, and during that time there is no way to see the sample. I also note that observers typically become inattentive during a number of unsuccessful trials. I myself failed to notice, tonight, when Ms. Visser removed her fourth heart from perfusion and placed it in the dewar. I was tired and was momentarily distracted. I believe that Ms. Visser is sincere and honorable, but if she were tempted to cut any corners in her procedures, it would be relatively easy to do so after some unsuccessful attempts. Of course, a properly situated probe inside the heart, or attached to its outside, would allay these doubts; but I was told that no such probe has been used. Bearing all this in mind, and also bearing in mind the severe freezing damage that I witnessed, I have to conclude that I found absolutely no evidence in favor of Ms. Visser's cryoprotectant. It's still possible, of course, that we were just unlucky today, and valid results may have been obtained previously. Other News About Olga Visser On Saturday (the first day of the Alcor conference) Ms. Visser stood before an audience of about 40 attendees and made a short speech urging cryonicists to cooperate and work together. She obviously realized that this plea for harmony contrasted oddly with her online persona. "A lot of people probably thought I'd ride in on a broom," she said. But she told us that she is a shy, decent, pleasant person. In fact, she claimed that her combative messages on the Net were not written by her at all. Her husband Zigi had typed some of them; others had been composed by an employee of the South African Government who has been assigned to protect Ms. Visser from her critics and keep her away from journalists at all times. Ms. Visser said that the only messages she wrote herself were the strictly factual ones describing experimental procedure. Well, I already noticed that the factual messages were formatted with a different line length from the ones that flamed her critics so savagely. On the other hand, as one cynic remarked, if Ms. Visser suffers from multiple personality disorder, we should expect her hostile personality to use different text formatting from her kinder, gentler personality. After her short self-introduction, Ms. Visser mentioned a few interesting details about her work. She said she had frozen a pig heart initially, but switched to rat hearts because they are cheaper and more plentiful. Funding is obviously a problem in South Africa, where the government gives highest priority to AIDS research. Ms. Visser said that she did not get her own laboratory until a month ago, and she had been constantly frustrated by the unwillingness of assistants to work long hours. She hopes ultimately to relocate in the United States, where people are more willing to work hard. She endorsed the concept of cryonics. "The hope of everyone is to be young forever," she said. Ideally, we should eat right, not smoke, and "live in the woods" (presumably, away from pollution). Still, she said, "since this is not possible, the second-best way is to be frozen and come back in perfect health at a time when all diseases can be cured." I noted that Ms. Visser herself is a fairly heavy smoker. When she was asked why her research hasn't been repeated elsewhere, she responded that a group in Australia is working on livers using her proprietary cryoprotectant. "They brought a liver back that was stored for three days," she claimed. "And we have people working in London as well." She did not specify names of researchers, or affiliations. Her next step, she said, will be to cryopreserve a pig heart, keep it in liquid nitrogen for a few days, then rewarm it and transplant it back into a pig. Since she belongs to a thoracic surgery department, she is not allowed to work on any organ other than hearts. She does want to expand her techniques to other organs, though, and sees no reason why her cryoprotectant shouldn't scale up to preserve human brains. She also wants to establish a bank of frozen skin, because the European skin grafts that are imported to South Africa are unsuitable for Black Africans. When will we learn the composition of her cryoprotectant? "Very soon," she said. By this she seemed to mean that the news will be circulated when her paper on rat hearts is finally published. On this topic, the news is as follows. The rat-heart paper was the first paper she ever wrote. In her naivety, she failed to include some procedural details. Consequently, the paper was sent back for revisions, which have now been made. She claims that her coworkers want to submit the paper to Science magazine, but she feels that it would be "unfair" not to resubmit it to the cryobiology magazine where it was originally sent. She is hoping to do this "soon" and hopes for publication "before June." She finished up with a telling self-description. "If I want to do something," she said, "I do it. I go against most other people, I'll just go ahead and do it, in any country, and then I'll answer questions afterward." Unfortunately, she had been warned by her lawyers not to answer any questions about her AIDS research, so we learned nothing new on this topic. Mystery Ingredient--Revealed While Ms. Visser's agents were busily threatening to sue anyone and everyone who dared to state the composition of the VisserStuff online, I have to report that a fairly well known Alcor member inadvertantly confirmed to me that Ms. Visser's cryoprotectant is, in fact, exactly the stuff that many people have said it is. The Alcorian speculated that trace impurities may be the reason why Visser's stock of the chemical, which originates in South Africa, has worked on rat hearts while American attempts to duplicate her work have failed. In other words, the Alcorian did _not_ suggest that the U.S. researchers have been using the wrong chemical altogether; merely that their supply of it may be slightly polluted. Subsequently, a _second_ Alcorian said exactly the same thing. I believe this removes the last vestige of mystery from the mystery ingredient. We know what it is; now we just need some repeatable results. I understand that Alcor has been unable to obtain these results when Ms. Visser is not present. I hope someone, somewhere will be able to do so; otherwise, Olga Visser's claims will remain unverified. PS. In her rat-heart experiments today (Sunday) Ms. Visser used a supply of cryoprotectant that she brought with her from South Africa. Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=7625